These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16313545)

  • 1. Percutaneous closure of patent foramen ovale.
    Bijl JM; Ruygrok PN; Hornung TS; Wilson NJ; West T
    Intern Med J; 2005 Dec; 35(12):706-10. PubMed ID: 16313545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventional closure with Amplatzer PFO occluder of patent foramen ovale in patients with paradoxical cerebral embolism.
    Chatterjee T; Petzsch M; Ince H; Rehders TC; Körber T; Weber F; Schneider H; Auf der Maur C; Nienaber CA
    J Interv Cardiol; 2005 Jun; 18(3):173-9. PubMed ID: 15966921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
    Manolis AS
    Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Butera G; Bini MR; Chessa M; Bedogni F; Onofri M; Carminati M
    Ital Heart J; 2001 Feb; 2(2):115-8. PubMed ID: 11256538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
    Manolis AS; Koulouris S; Rouska E; Pyrros J
    Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial.
    Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM;
    Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism.
    Khositseth A; Cabalka AK; Sweeney JP; Fortuin FD; Reeder GS; Connolly HM; Hagler DJ
    Mayo Clin Proc; 2004 Jan; 79(1):35-41. PubMed ID: 14708946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.
    Windecker S; Wahl A; Chatterjee T; Garachemani A; Eberli FR; Seiler C; Meier B
    Circulation; 2000 Feb; 101(8):893-8. PubMed ID: 10694529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter closure of patent foramen ovale associated with atrial septal aneurysm with Amplatzer Cribriform septal occluder.
    Musto C; Cifarelli A; Pandolfi C; De Felice F; Fiorilli R; Caferri G; Violini R
    J Invasive Cardiol; 2009 Jun; 21(6):290-3. PubMed ID: 19494408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of patent foramen ovale closure for paradoxical emboli without echocardiographic guidance.
    Varma C; Benson LN; Warr MR; Yeo E; Yip J; Jaigobin CS; Webb G; McLaughlin PR
    Catheter Cardiovasc Interv; 2004 Aug; 62(4):519-25. PubMed ID: 15274165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent foramen ovale closure following cryptogenic stroke or transient ischaemic attack: Long-term follow-up of 301 cases.
    Mirzaali M; Dooley M; Wynne D; Cooter N; Lee L; Haworth P; Saha R; Gainsborough N; Hildick-Smith D
    Catheter Cardiovasc Interv; 2015 Nov; 86(6):1078-84. PubMed ID: 26105198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of day case patent foramen ovale (PFO) closure facilitated by intracardiac echocardiography.
    Ponnuthurai FA; van Gaal WJ; Burchell A; Mitchell AR; Wilson N; Ormerod OJ
    Int J Cardiol; 2009 Jan; 131(3):438-40. PubMed ID: 18037512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.
    Wahl A; Krumsdorf U; Meier B; Sievert H; Ostermayer S; Billinger K; Schwerzmann M; Becker U; Seiler C; Arnold M; Mattle HP; Windecker S
    J Am Coll Cardiol; 2005 Feb; 45(3):377-80. PubMed ID: 15680715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
    Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter patent foramen ovale closure using the Premere PFO occlusion system.
    Donti A; Giardini A; Salomone L; Formigari R; Picchio FM
    Catheter Cardiovasc Interv; 2006 Nov; 68(5):736-40. PubMed ID: 17039524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFO closure with only fluoroscopic guidance: 7 years real-world single centre experience.
    Mangieri A; Godino C; Montorfano M; Arioli F; Rosa I; Ajello S; Piraino D; Monello A; Pavon AG; Viani G; Magni V; Cappelletti A; Margonato A; Colombo A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):105-12. PubMed ID: 25382155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.
    von Bardeleben RS; Richter C; Otto J; Himmrich L; Schnabel R; Kampmann C; Rupprecht HJ; Marx J; Hommel G; Münzel T; Horstick G
    Int J Cardiol; 2009 May; 134(1):33-41. PubMed ID: 18715659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale with paradoxical embolism: mid-term results of transcatheter closure in 256 patients.
    Onorato E; Melzi G; Casilli F; Pedon L; Rigatelli G; Carrozza A; Maiolino P; Zanchetta M; Morandi E; Angeli S; Anzola GP
    J Interv Cardiol; 2003 Feb; 16(1):43-50. PubMed ID: 12664817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome.
    Post MC; Van Deyk K; Budts W
    Acta Cardiol; 2005 Oct; 60(5):515-9. PubMed ID: 16261783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.